NextEvo Signals Ant Group's Bold Return to AI Innovation
Ant Group has launched NextEvo, a dedicated artificial intelligence unit led by former Google engineer Xu Peng, marking the fintech giant's renewed push into AI innovation. The move comes as regulatory pressures ease and the company positions itself to capitalise on China's booming AI market.
The establishment of NextEvo reflects broader ambitions within China's tech sector, where companies are racing to develop competitive AI capabilities. This strategic pivot arrives at a crucial moment for Ant Group, as Beijing shows signs of relaxing restrictions that have hampered the company's growth since 2020.
NextEvo Takes Centre Stage in Ant's AI Strategy
NextEvo will serve as the command centre for Ant Group's core AI initiatives, coordinating development across multiple fronts. The unit will oversee the company's homegrown large language model Bailing, whilst managing AI algorithms, natural language processing capabilities, and AI-generated content operations.
The timing aligns with significant momentum in Ant's AI applications. The company's AI-powered services are already showing remarkable traction, particularly in healthcare and payments sectors where artificial intelligence is transforming user experiences.
Ant's approach mirrors strategies employed by other Chinese tech giants. Companies like Tencent have joined China's AI race with new reasoning models, whilst Chinese AI models now lead global token rankings in performance metrics.
By The Numbers
- Alipay AI Pay surpassed 100 million users by February 2026, processing over 120 million transactions in a single week
- AQ health app exceeded 100 million total users during Chinese New Year 2026, becoming the world's largest AI-native health app
- China's online healthcare market reached 480 billion yuan (£55 billion) in 2025, where Ant deploys AI Doctor Agents
- Ant Group's quarterly profit fell an estimated 91% year-over-year due to heavy AI investment spending
- AQ's Doctor Agents handled 27 million health inquiries last year, trained by over 1,000 medical professionals
Regulatory Climate Shifts in Ant's Favour
The launch of NextEvo coincides with encouraging signals from Chinese regulators. Beijing appears increasingly willing to ease restrictions that have constrained Ant Group's operations, including potential approval of a crucial credit business licence.
This regulatory thaw could prove instrumental in reviving Ant's stalled initial public offering plans. The company's IPO, once valued at over $30 billion, was suspended in late 2020 amid regulatory crackdowns on China's tech sector.
"The formation of NextEvo marks a new chapter in our journey to leverage AI for growth," said a company spokesperson, highlighting the strategic importance of the new unit.
Industry observers note the broader implications of China's shifting stance on AI development. The country is increasingly recognising AI as a critical component of technological sovereignty and economic competitiveness.
Healthcare AI Drives User Engagement
Ant's AQ health application exemplifies the company's AI success, particularly among users in smaller Chinese cities. The platform drew 52% of new users from third-tier cities and below during a recent three-week period, demonstrating AI's appeal beyond major metropolitan areas.
The healthcare focus addresses genuine market needs in China, where doctor shortages create opportunities for AI-assisted medical services. AQ's AI Doctor Agents provide standardised basic care recommendations, potentially improving healthcare access across the country's 1.4 billion population.
"If AI can help standardise basic care, that could be beneficial," noted David Feng, chief executive of Hangzhou-based healthcare startup NoCode, commenting on the potential impact of AI in Chinese healthcare.
Usage patterns show strong engagement, with 30 million monthly active users submitting 10 million health questions daily through the platform. This level of interaction suggests genuine utility rather than novelty-driven adoption.
Competition Intensifies Across Chinese AI Landscape
Ant's NextEvo initiative enters an increasingly competitive environment. Chinese AI companies are revolutionising the industry with cost-efficient innovations, whilst free Chinese AI models claim to beat GPT-5 in performance benchmarks.
The competitive pressure extends beyond domestic markets, as Chinese AI models dominate global derivatives trading and other international applications. This success demonstrates the global potential of Chinese AI innovation.
Regional governments are also stepping up support. Hong Kong backs new AI research institute with billions in funding, creating additional momentum for the sector's development across Greater China.
| AI Application | User Base | Key Metric | Growth Period |
|---|---|---|---|
| Alipay AI Pay | 100 million | 120 million transactions/week | February 2026 |
| AQ Health App | 100 million total | 10 million questions/day | Chinese New Year 2026 |
| AI Doctor Agents | 27 million inquiries | 1,000+ doctor trainers | 2025 annual |
Investment Priorities and Market Positioning
Ant Group's substantial AI investments reflect long-term strategic thinking despite short-term profit pressures. The company's willingness to accept a 91% year-over-year profit decline demonstrates commitment to AI leadership in the Chinese market.
Key investment areas include:
- Large language model development through the Bailing platform
- Healthcare AI applications targeting China's massive population
- Payment system AI integration for enhanced user experiences
- Natural language processing capabilities for multilingual operations
- AI-generated content systems for diverse business applications
- Algorithm development for financial services optimisation
The investment strategy positions Ant Group to capture value as AI adoption accelerates across Chinese consumer and business markets. Early leadership in key verticals like healthcare and payments could provide sustainable competitive advantages.
What is NextEvo's primary mission within Ant Group?
NextEvo serves as Ant Group's centralised AI command centre, coordinating development of the Bailing language model, AI algorithms, natural language processing, and AI-generated content operations across all business units.
How significant is Ant's healthcare AI achievement?
AQ became the world's largest AI-native health app with 100 million users, processing 10 million daily health questions through AI Doctor Agents trained by over 1,000 medical professionals.
What regulatory changes are helping Ant Group's AI ambitions?
Beijing is showing willingness to ease restrictions on Ant Group, potentially granting key credit business licences that could revive the company's stalled IPO plans and enable expanded operations.
How does Ant's AI investment impact profitability?
Ant Group accepted a 91% year-over-year profit decline due to heavy AI spending, reflecting the company's commitment to long-term AI leadership despite short-term financial pressures.
What makes Chinese AI development globally competitive?
Chinese AI companies achieve cost-efficient innovations whilst delivering performance that matches or exceeds Western models, creating competitive advantages in both domestic and international markets.
The establishment of NextEvo marks a pivotal moment for both Ant Group and China's AI landscape. As regulatory barriers diminish and technological capabilities advance, the stage is set for renewed competition and innovation.
What do you think NextEvo's launch means for the global AI competitive landscape? Will Ant Group's healthcare AI success translate to other sectors? Drop your take in the comments below.
Latest Comments (4)
NextEvo managing all those different AI functions, from LLMs to NLP and AIGC, sounds like a proper undertaking. I mean, coordinating efforts across that many distinct areas, all under one new unit... that's a rather ambitious remit, isn't it? Especially for a company that's been through the regulatory wringer a bit. I'm keen to see how they actually deliver on that, because integration across such diverse AI applications is never straightforward. Will be interesting to revisit this in six months' time to see how they're getting on.
good to see NextEvo focusing on LLMs and NLP. here in Indonesia, we're still figuring out how to best adapt these models for Bahasa. data scarcity has been a real challenge for e-commerce applications, especially for nuanced product descriptions. curious how Bailing handles less common languages.
Great to see Ant Group pushing on with NextEvo, especially with Bailing. It really shows how global the LLM race is becoming. Reminds me a bit of the energy up here in Manchester.
It's interesting to see Ant Group formalizing their AI efforts with NextEvo. We've certainly observed similar consolidations of AI initiatives within larger tech companies here in Japan, often to streamline research and development, especially for projects involving foundation models like their Bailing LLM. The coordinated management of NLP specifically, often benefits from such a centralized approach, allowing for more consistent application across different product lines. I'm actually presenting some recent multimodal work at AAAI next month that touches on similar organizational structures and their impact on benchmark performance.
Leave a Comment